← FDA Drug Approvals (Drugs@FDA)
TADALAFIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NORVIUM BIOSCIENCE · Approved 2019-04-29
Drug application
- FDA Application #
ANDA206957- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TADALAFIL
- Generic name
- Tadalafil
- Active ingredients
- TADALAFIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- NORVIUM BIOSCIENCE
- First approval
- 2019-04-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown